Novartis AG - Cash and Equivalents

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 9.56 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Cash and Equivalents" stands at 9.56 Billion USD. This represents an increase of 43.57 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -29.78 percent compared to the value the year prior.
The 1 year change in percent is -29.78.
The 3 year change in percent is 9.51.
The 5 year change in percent is 6.25.
The 10 year change in percent is 57.59.

The Serie's long term average value is 8.27 Billion United States Dollars. It's latest available value, on 09/30/2025, is 15.51 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +163.61%.
The Serie's change in percent from it's maximum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is -31.74%.